Madopar HBS Capsule

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

levodopum, benserazidum

Available from:

Roche Pharma (Schweiz) AG

ATC code:

N04BA02

INN (International Name):

levodopum, benserazidum

Pharmaceutical form:

Capsule

Composition:

levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, hypromellosum, oleum vegetabile hydrogenatum, calcii hydrogenophosphas, mannitolum, povidonum K 30, talcum, magnesii stearas, Kapselhülle: E 132, E 171, gelatina, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (rubrum), pro capsula.

Class:

B

Therapeutic group:

Synthetika

Therapeutic area:

Morbo Di Parkinson, Delle Gambe Senza Riposo-Syndrom

Authorization status:

zugelassen

Authorization date:

1987-06-18